Cocaine-induced pulmonary complications: A diagnosis of waiting and watching


  Table of Contents     CASE REPORT Year : 2021  |  Volume : 38  |  Issue : 4  |  Page : 362-364  

Cocaine-induced pulmonary complications: A diagnosis of waiting and watching

Rohit Munagala1, Varsha Chiruvella1, Darko Pucar2, Jayanth Keshavamurthy1
1 Department of Radiology, Medical College of Georgia at Augusta University, Augusta, GA, USA
2 Department of Radiology, Yale School of Medicine, New Haven, CT, USA

Date of Submission08-Mar-2021Date of Acceptance20-Mar-2021Date of Web Publication03-Jul-2021

Correspondence Address:
Varsha Chiruvella
Medical College of Georgia at Augusta University, 1120 15th St. Augusta, GA 30912
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Crossref citationsCheck

DOI: 10.4103/lungindia.lungindia_164_21

Rights and Permissions

   Abstract 


Pulmonary complications of cocaine among users are common. Manifestations include lung congestion, intra-alveolar edema, and diffuse alveolar hemorrhage (DAH). Direct cellular toxicity, eosinophilia, barotrauma, and vasoactive effects of cocaine are believed to induce DAH. We present a rare case of cocaine-associated focal alveolar hemorrhage mimicking malignancy on imaging. Initially contemplated biopsy was avoided based on rapid growth of concerning lung lesion, with subsequent near resolution on follow-up. This case illustrates the importance of epidemiologic and temporal multimodality correlation when evaluating indeterminate lung lesions.

Keywords: Cocaine, fluorodeoxyglucose positron emission tomography/computed tomography, focal alveolar hemorrhage, lung injury, unnecessary biopsy


How to cite this article:
Munagala R, Chiruvella V, Pucar D, Keshavamurthy J. Cocaine-induced pulmonary complications: A diagnosis of waiting and watching. Lung India 2021;38:362-4
How to cite this URL:
Munagala R, Chiruvella V, Pucar D, Keshavamurthy J. Cocaine-induced pulmonary complications: A diagnosis of waiting and watching. Lung India [serial online] 2021 [cited 2021 Jul 4];38:362-4. Available from: 
https://www.lungindia.com/text.asp?2021/38/4/362/320586    Introduction Top

Cocaine has vasoactive properties resulting in eosinophilia, cellular toxicity, and barotrauma with alveolar hemorrhage.[1] While cocaine-associated diffuse alveolar hemorrhage is relatively common, focal alveolar hemorrhage (FAH) is only reported in isolated cases without true numbers regarding prevalence.[2],[3],[4],[5] Although FAH may mimic malignancy on imaging, this case illustrates the importance of follow-up and re-evaluation before taking biopsy for benign etiologies. Upon re-evaluation, rapid growth and eventual resolution of the lesion is apparent. In contrast, lung neoplasms naturally do not have such rapid size enlargement, with a reported mean tumor volume doubling time of 166 days.[6] Cessation of cocaine, oxygenation, and glucocorticoids remain the mainstay management of cocaine-induced alveolar hemorrhage.[4]

   Case Report Top

A 73-year-old man with long-standing history of smoking tobacco, cocaine, and cannabis presented with acute chest pain. Initial chest X-ray (CXR) showed two lung nodules up to 2.7 cm [Figure 1]A, red arrows – left lower lobe (LLL), black arrows – right upper lobe (RUL)]. Subsequent CXR and chest computed tomography (CT) 4 days later showed the LLL nodule increase to 5 cm [Figure 1]B1, [Figure 1]B2, [Figure 1]B3, red arrows]. Fluorodeoxyglucose positron emission tomography/CT (FDG PET/CT) performed showed an intensely avid (maximum standardized uptake value: 7.4) LLL lesion measuring 7 cm, with photopenic areas suggestive of necrosis [Figure 1]C1 and [Figure 1]c2, red arrows]. The RUL nodule was also intensely avid [Figure 1]C1, black arrow]. Although biopsy was initially suggested by the PET reader, the tumor board determined that the lesion's rapid growth was inconsistent with malignancy. Indeed, the lesions nearly resolved with minimal residual fibrosis on chest CT approximately a month later [Figure 1]d, red arrows]. Subsequent analysis determined that the presentation was most consistent with a rare cocaine-induced FAH.[7],[8],[9]

Figure 1: Computed tomography and fluorodeoxyglucose positron emission tomography modality imaging of cocaine-inducible focal alveolar hemorrhage reveals rapid doubling and resolution and exhibits a solid-like, hazy appearance and preserved underlying bronchial structures and vasculature. (A) Initial chest X-ray showing two lung nodules up to 2.7 cm (red arrows – left lower lobe, black arrows – right upper lobe. (B1) Subsequent chest X-ray illustrating left lower lobe nodule increase to 5 cm (red arrows). (B2) Subsequent coronal chest computed tomography illustrating left lower lobe nodule increase to 5 cm (red arrows). (B3) Subsequent axial chest computed tomography illustrating left lower lobe nodule increase to 5 cm (red arrows). (C1) Intensely avid, 7 cm lower lobe nodule lesion on coronal fluorodeoxyglucose positron emission tomography/computed tomography with photopenic areas suggestive of necrosis (red arrows) with additional intensely avid right upper lobe nodule (black arrows). (C2) Intensely avid, 7 cm lobe nodule lesion on axial fluorodeoxyglucose positron emission tomography/computed tomography with photopenic areas suggestive of necrosis (red arrows). (D) Resolved pulmonary lesion with minimal residual fibrosis on axial chest computed tomography 1 month after initial imaging (red arrows)

Click here to view

   Discussion Top

Cocaine-induced FAH may mimic benign and malignant conditions on imaging. In fact, there are several benign neoplasms that mimic lung malignancies on FDG PET-CT.[10],[11],[12],[13],[14],[15],[16] Pulmonary hamartoma is the most common benign neoplasm and is composed of mesenchymal tissues such as cartilage, fat, and connective tissues.[11],[17] Hamartomas appear as a smooth, round, or lobulated mass on CT. However, in the absence of common features of fat and central calcification, it is difficult to discern pulmonary hamartoma from a round or lobulated primary lung malignancy.[13],[18] Hamartomas also usually show low-grade uptake of FDG, appearing analogous to lung cancers with low metabolic rates like bronchoalveolar carcinoma.[12],[19] Focal inflammatory and infectious conditions may further complicate a diagnosis of cocaine-induced FAH.[20],[21],[22],[23],[24],[25],[26] Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia similarly presents with necrotizing granulomatous inflammation, mimicking aggressive malignancy on FDG PET.[20] Tuberculosis (TB) is a chronic granulomatous infection caused by Mycobacterium tuberculosis. Similar to FAH, active TB presents with central necrosis and elevated FDG uptake on PET-CT, attributable to high macrophage count.[21],[22] Fast-growing malignancy like small-cell lung cancer may also appear comparable to cocaine-induced FAH due to its highly rapid growth, with a mean doubling time of approximately 86 days.[6],[27] By waiting and re-evaluating, unnecessary biopsy can be avoided in patients with cocaine-induced pulmonary injury.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Acknowledgment

We specially thank Dr. Pucar with the Yale School of Medicine and Dr. Keshavamurthy with the Augusta University Medical College of Georgia for providing original case images and guidance for this report.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 

   References Top
1.Murray RJ, Albin RJ, Mergner W, Criner GJ. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest 1988;93:427-9.  Back to cited text no. 1
    2.Dushay KM, Evans SK, Ghimire S, Liu J. Cocaine-induced diffuse alveolar hemorrhage: A case report and review of the literature. R I Med J (2013) 2016;99:34-6.  Back to cited text no. 2
    3.Underner M, Perriot J, Wallaert B, Peiffer G, Meurice JC, Jaafari N. Alveolar hemorrhage and cocaine use. Rev Mal Respir 2018;35:134-48.  Back to cited text no. 3
    4.Jiménez-Zarazúa O, López-García JA, Arce-Negrete LR, Vélez-Ramírez LN, Casimiro-Guzmán L, Mondragón JD. Alveolar hemorrhage associated with cocaine consumption. Heart Lung 2018;47:525-30.  Back to cited text no. 4
    5.Mégarbane B, Chevillard L. The large spectrum of pulmonary complications following illicit drug use: Features and mechanisms. Chem Biol Interact 2013;206:444-51.  Back to cited text no. 5
    6.Arai T, Kuroishi T, Saito Y, Kurita Y, Naruke T, Kaneko M. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 1994;24:199-204.  Back to cited text no. 6
    7.de Almeida RR, Zanetti G, Souza AS Jr., de Souza LS, Silva JL, Escuissato DL, et al. Cocaine-induced pulmonary changes: HRCT findings. J Bras Pneumol 2015;41:323-30.  Back to cited text no. 7
    8.Mengar M, Gupta N, Chakrabarti S, Aggarwal V, Shah K, Ish P. Cocaine abuse induced diffuse alveolar haemorrhage: A rare entity. Monaldi Arch Chest Dis 2020;90. doi: 10.4081/monaldi.2020.1191.  Back to cited text no. 8
    9.de Almeida RR, de Souza LS, Mancano AD, Souza As Jr., Irion KL, Nobre LF, et al. High-resolution computed tomographic findings of cocaine-induced pulmonary disease: A state of the art review. Lung 2014;192:225-33.  Back to cited text no. 9
    10.Wilson B, Becker A, Estes T, Keshavamurthy J, Pucar D. Adrenal hemangioma definite diagnosis on CT, MRI, and FDG PET in a patient with primary lung cancer. Clin Nucl Med 2018;43:e192-4.  Back to cited text no. 10
    11.Furuya K, Yasumori K, Takeo S, Sakino I, Uesugi N, Momosaki S, et al. Lung CT: Part 1, Mimickers of lung cancer – Spectrum of CT findings with pathologic correlation. AJR Am J Roentgenol 2012;199:W454-63.  Back to cited text no. 11
    12.Wang W, Song J, Shi J, Hu H, Wu Y, Yan J, et al. Slight uptake of (18) F-FDG on positron emission tomography in pulmonary hamartoma: A case report. Oncol Lett 2015;10:430-2.  Back to cited text no. 12
    13.Lu Z, Qian F, Chen S, Yu G. Pulmonary hamartoma resembling multiple metastases: A case report. Oncol Lett 2014;7:1885-8.  Back to cited text no. 13
    14.Pavithran K, Manoj P, Vidhyadharan G, Shanmughasundaram P. Inflammatory myofibroblastic tumor of the lung: Unusual imaging findings. World J Nucl Med 2013;12:126-8.  Back to cited text no. 14
[PUBMED]  [Full text]  15.Kobashi Y, Fukuda M, Nakata M, Irei T, Oka M. Inflammatory pseudotumor of the lung: Clinicopathological analysis in seven adult patients. Int J Clin Oncol 2006;11:461-6.  Back to cited text no. 15
    16.Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO. Inflammatory pseudotumor: The great mimicker. AJR Am J Roentgenol 2012;198:W217-27.  Back to cited text no. 16
    17.Bateson EM. An analysis of 155 solitary lung lesions illustrating the differential diagnosis of mixed tumours of the lung. Clin Radiol 1965;16:51-65.  Back to cited text no. 17
    18.Siegelman SS, Khouri NF, Scott WW Jr., Leo FP, Hamper UM, Fishman EK, et al. Pulmonary hamartoma: CT findings. Radiology 1986;160:313-7.  Back to cited text no. 18
    19.Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998;170:935-9.  Back to cited text no. 19
    20.Hsu J, Jia L, Pucar D, Williams H, Keshavamurthy J. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and granulomatous inflammation mimicking high-grade malignancy on FDG-PET/CT. Clin Nucl Med 2017;42:47-9.  Back to cited text no. 20
    21.Nachiappan AC, Rahbar K, Shi X, Guy ES, Mortani Barbosa EJ Jr., Shroff GS, et al. Pulmonary tuberculosis: Role of radiology in diagnosis and management. Radiographics 2017;37:52-72.  Back to cited text no. 21
    22.Yang CM, Hsu CH, Lee CM, Wang FC. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med 2003;17:407-10.  Back to cited text no. 22
    23.Erdoğan Y, Özyürek BA, Özmen Ö, Yılmaz Demirci N, Duyar SŞ, Dadalı Y, et al. The Evaluation of FDG PET/CT scan findings in patients with organizing pneumonia mimicking lung cancer. Mol Imaging Radionucl Ther 2015;24:60-5.  Back to cited text no. 23
    24.Yang PS, Lee KS, Han J, Kim EA, Kim TS, Choo IW. Focal organizing pneumonia: CT and pathologic findings. J Korean Med Sci 2001;16:573-8.  Back to cited text no. 24
    25.Shin HJ, Kim MS, Kho BG, Park HY, Kim T, Park C, et al. Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report. BMC Pulm Med 2020;20:71.  Back to cited text no. 25
    26.Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18) F-FDG PET/CT. Lung Cancer 2009;65:180-6.  Back to cited text no. 26
    27.Harris K, Khachaturova I, Azab B, Maniatis T, Murukutla S, Chalhoub M, et al. Small cell lung cancer doubling time and its effect on clinical presentation: A concise review. Clin Med Insights Oncol 2012;6:199-203.  Back to cited text no. 27
    
  [Figure 1]

 

Top   

留言 (0)

沒有登入
gif